SectorBiological Technology
Established Date27/07/2021
Listing Date19/02/2025
ExchangeNASDAQ Stock Exchange
Full-time Employees27
Fiscal Year Ends31/12
Security TypeCommon stock
Office addressWilhelm Gutbrod Str 21B, 60437, Frankfurt am Main, Germany
Business
IntroductionAnbio Biotechnology was incorporated in the Cayman Islands on July 27, 2021. The company is committed to the advancement of medical technology and the provision of in vitro diagnostic products. Their unwavering commitment is to transform the diagnostic landscape on a global scale, facilitating a paradigm shift towards personalized and decentralized diagnostic solutions.
